LifeScan to stay in Inverness after £1.57 billion sale

Life Sciences Scotland welcomes the news that LifeScan Scotland, intends to continue operations in Inverness after acquiring its parent company for £1.57 billion. A question mark had hung over the future of the facility, which has a workforce of around 1,000 making blood glucose monitoring systems for world-wide markets, since J&J announced a “strategic review” of its diabetes care companies last January. Yesterday, J&J confirmed it...

New tuberculosis test dramatically cuts diagnosis time

University of St Andrews team has developed an analysis that provides result in four hours. Scientists have developed a way to dramatically cut the time needed to diagnose tuberculosis in the developing world. The treatable disease still causes about one million deaths every year, with diagnosis often taking months to confirm, but a team at the University of St Andrews has developed an analysis that...

Activity Key to Optimising Stroke Recovery

Emphasising the importance of sustained rehabilitation can help health services cope with rising numbers of people surviving a stroke, a University of Dundee expert has said. Dr Jacqui Morris, Reader in Rehabilitation Research at the University’s School of Nursing and Health Sciences, said that providing long-lasting support for those living with the aftermath of the condition is now more essential than ever. It comes as...

UV light treatment can save millions while helping patients

Treating severe skin conditions with UV light rather than creams, pills and injections could save the NHS millions of pounds while improving patient outcomes, according to a new University of Dundee study. Dr John Foerster and colleagues from the University’s School of Medicine found the annual per-patient cost of filtered UV light treatment, known as phototherapy, to be around £250. This is one-sixth of the...

BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology

BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed compound. The agreement includes an upfront payment, milestones and future royalties. BDD’s proprietary OralogiK™ technology enables the oral delivery of single, multi-dose or combination drugs at pre-determined times between one and 12 hours after administration...

Canon Medical Joins Clinical Innovation Zone

The University of Glasgow has welcomed new tenants, Canon Medical Research Europe Ltd, to the Clinical Innovation Zone (CIZ) at the Imaging Centre of Excellence (ICE) on the Queen Elizabeth University Hospital campus. Canon Medical Research Europe Ltd is a world leader in creating software for analysis and visualisation of CT, MRI, US and XR images. The company opened their Glasgow office within the CIZ...

Top